Navigation Search

Select your location and role to view strategy and fund content

  • Global homepage
  • Australia
  • Botswana
  • Denmark
  • Deutschland
  • España
  • Finland (Suomi)
  • France
  • Hong Kong (香港)
  • Ireland
  • Italia
  • Luxembourg
  • Namibia
  • Nederland
  • Norway
  • Österreich
  • Portugal
  • Singapore
  • South Africa
  • Sweden (Sverige)
  • Switzerland
  • United Kingdom
  • United States
  • International
Individual Investor
  • Professional Investor
  • Individual Investor

This site is for retail investors. We recommend that you seek independent financial advice to ensure our Funds are suitable for your investment needs. Please remember capital is at risk and past performance is not a guide to the future.

By entering you agree to our Terms & Conditions

Login to My Investec

Investec Global Franchise Fund


Key Benefits:

Invests in world leading companies with strong brands

Focuses on quality businesses with high customer loyalty, strong brands, no debt and are more resilient in times of economic uncertainty.

Focuses on industries with stable growth

The Fund currently focuses on technology, consumer staples and healthcare which could deliver consistent returns throughout the cycle.

Seeks to deliver excellent consistent long-term performance

The Fund has weathered volatile markets while seeking long-term outperformance



Learn more about Global Franchise Fund

A high-conviction portfolio of global leaders:

The Fund seeks to invest in some of the world's leading companies from around the globe, many of which have long trading histories. These companies typically have strong brands, patents/copyrights and high customer loyalty that creates the competitive advantage of high barriers to entry and provides excellent long-term returns and resilience to investors.

These competitive advantages are most prevalent in the technology, consumer staples and health care sectors where the Fund is currently primarily focused.

Company name Brands Weight2 Year est.
Johnson & Johnson Listerine, Johnson Baby, Clean & Clear 5.6% 1886
5.6% 1958
Nestlé Nescafé, Maggi, Dairy Farm, Dreyers 4.8% 1905
Roche Holding
Rituxan, Avastin, Herceptin
4.1% 1896
Reckitt Benckiser Vanish, Dettol, Strepsils 3.8% 1823


Proven Track record

YTD 6 months 1 year3 years p.a.5 years p.aSince launch* p.a.
Fund  18.2% 7.2% 12.4% 8.4% 9.1% 11.5%
Fund (including 5% initial charge) 12.3% 1.8% 6.8% 6.5% 8.0% 10.8%
Sector average (including initial charge) 12.4% 5.4% 12.7% 4.8% 8.4% 9.3%
MSCI AC World Index 17.3% 9.7% 18.6% 7.4% 10.2% 11.2%


Learn more about Global Franchise Fund

1 Source: © 2017 Morningstar. All Rights Reserved. Data as of 30 September 2017, based on A Acc share class. Morningstar rates mutual funds based on how well they’ve performed (after adjusting for risk and accounting for all sales charges) in comparison to similar funds, the top 10% of funds receive five stars, the next 22.5% four stars, the middle 35% three stars, the next 22.5% two stars, and the bottom 10% receive one star. 2 Source: Investec Asset Management, as at 30 September 2017. This is not a buy, sell or hold recommendation forany particular security. The portfolio may change significantly over a short period of time. 3 Source: Morningstar, as at 30 September 2017, based on NAV to NAV (inclusive of all annual management fees) of A Acc Share class, gross income reinvested, in USD. YTD refers to year-to-date performance. Sector average refers to the unweighted average of the primary share of the Singapore registered funds in the Morningstar Global Large-Cap Blend Equity sector. *Since launch performance figures are calculated from the launch date of the Fund on 4 July 2009. 4 Source: Investec Asset Management, as at 30 September 2017.

Portfolio Manager 

Clyde Rossouw

  • 18 years with the firm
  • 23 years industry experience

Watch the video
Launch date 04/07/2009
Fund size US$3,437.7 million
Initial charge A share – Up to 5% of the amount you buy
Annual management fee A share – 1.50%

LU0426412945 (A Acc USD) 

LU0846948197 (A Acc EUR)

LU1043141396 (A Acc HKD) 

LU1121112475 (A Acc USD Hedged (Portfolio – AC))

LU0855493085 (A Acc SGD Hedged (Reference))

LU0869878131 (A Acc CHF Hedged (Reference))

LU0426417589 (A Inc USD)

LU1194092331 (A Inc EUR)

LU0994945656 (A Inc-2 USD)

LU1043141123 (A Inc-2 HKD)

LU1022646571 (A Inc-2 AUD Hedged (IRD))

LU1172942267 (A Inc-2 CNH Hedged (IRD))

Bloomberg code




IGSGFAP LX (A Acc USD Hedged (Portfolio – AC))

IGFCASA LX (A Acc SGD Hedged (Reference))

IGFSASF LX (A Acc CHF Hedged (Reference))





IGFCA2D LX (A Inc-2 AUD Hedged (IRD))

IGFAI2H LX (A Inc-2 CNH Hedged (IRD))


The value of this investment, and any income generated from it, will be affected by changes in interest rates, general market conditions and other political, social and economic developments, as well as by specific matters relating to the assets in which it invests. The Fund’s investment objective will not necessarily be achieved and investors are not certain to make profits; losses may be made. The Fund may use or invest in financial derivatives. Past performance figures shown and any forecasts on the economy, stock or bond market, or economic trends that are targeted by the fund, are not indicative of future performance. Investment involves risks. Investors should read the Prospectus for details, including the risk factors. All the information contained in this communication is believed to be reliable but may be inaccurate or incomplete. Any opinions stated are honestly held but are not guaranteed and should not be relied upon. This is not a buy, sell or hold recommendation for any particular security. The portfolio may change significantly over a short period of time. This communication is provided for general information only. It is not an invitation to make an investment nor does it constitute an offer for sale.

The value of the shares in the fund and the income accruing to the shares, if any, may fall or rise. Potential investor should read the details of the Prospectus before deciding to subscribe for or purchase the Fund. Investment involves risk. Please refer to the Singapore Offering Documents (including the risk factors set out therein) and the relevant Product Highlights Sheet for details which are available at your bank or financial adviser. Investors may wish to seek advice from a financial adviser before making a commitment to purchase shares of the Fund. In the event that an investor chooses not to seek advice from a financial adviser, he/she should consider carefully whether the Fund in question is suitable for him/her. For more information, please contact your bank and financial advice. this document is issued by Investec Asset Management Singapore Pte Limited (company registration number: 201220398M).